Related Experiment Videos
Effect of clozapine on polypharmacy
S A Chong1, G J Remington, K Z Bezchlibnyk-Butler
1Schizophrenia Division, Clarke Institute of Psychiatry, Toronto, Canada. sachong@singnet.com.sg
Psychiatric Services (Washington, D.C.)
|February 2, 2000
Summary
Clozapine initiation in schizophrenia patients reduced polypharmacy by 31%. Prescribing patterns shifted, with fewer anticholinergics, carbamazepine, and benzodiazepines, but increased use of SSRIs and sodium valproate alongside clozapine.
Area of Science:
- Psychiatry
- Pharmacology
- Clinical Pharmacy
Background:
- Schizophrenia treatment often involves managing complex psychopharmacological regimens.
- Assessing medication changes after introducing novel treatments like clozapine is crucial for optimizing patient care.
- Understanding shifts in prescribing patterns informs clinical practice and drug utilization research.
Purpose of the Study:
- To evaluate changes in psychotropic prescribing patterns among outpatients with schizophrenia following the introduction of clozapine.
- To identify specific drug classes whose use decreased or increased concomitantly with clozapine initiation.
- To analyze the trend towards monotherapy versus polytherapy in schizophrenia management with clozapine.
Main Methods:
- Retrospective analysis of prescribing patterns.
- Data collection through computerized pharmacy records, case record reviews, and psychiatrist interviews.
- Comparison of medication use before and after clozapine initiation in a cohort of schizophrenia outpatients.
Main Results:
- A significant 31% decrease in patients using two or more psychotropic drugs was observed post-clozapine initiation.
- A trend towards using clozapine as monotherapy, without additional neuroleptics, was detected.
- Concomitant use decreased for anticholinergic agents, carbamazepine, and benzodiazepines.
- Selective serotonin reuptake inhibitors (SSRIs) and sodium valproate were more frequently prescribed with clozapine.
Conclusions:
- Clozapine initiation is associated with a reduction in psychotropic polypharmacy in schizophrenia outpatients.
- The findings suggest a move towards simplified medication regimens, though specific concomitant therapies (SSRIs, sodium valproate) remain common.
- Further research into the rationale and outcomes of these prescribing shifts is warranted.